Re-Engineering Clinical Trials: A Biopharma Summit on Capitol Hill

ICON plc, a global provider of drug and development solutions and services for the pharma, biotech and medical device industries, announced the release of its new book ‘Re-engineering Clinical Trials: Best Practices for Streamlining Drug Development’ on Monday (13/4/15).

In this book, ICON and industry leaders have asked and answered some critical questions about the fundamentals of clinical development.

To discuss the themes outlined in the book, Tufts Centre for the Study of Drug Development and ICON plc have organised a one-day biopharma summit in Washington D.C. including a keynote delivered by FDA Deputy Commissioner, Dr. Robert Califf.

More information about the event can be found here: http://csdd.tufts.edu/courses/special_events